This is a preview of subscription content, log in via an institution to check access.
Notes
Funded by Janssen-Cilag.
Reference
Mahlich J, et al. Hospitalization Rates and Therapy Costs of German Schizophrenia Patients Who are Initiated on Long-Acting Injectable Medication: A Mirror-Image Study. Clinical Drug Investigation : 9 Mar 2020. Available from: URL: http://dx.doi.org/10.1007/s40261-020-00900-y
Rights and permissions
About this article
Cite this article
LAI antipsychotics may reduce costs and hospitalisations in Germany. PharmacoEcon Outcomes News 849, 18 (2020). https://doi.org/10.1007/s40274-020-6669-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6669-9